Search results
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
Motley Fool via Yahoo Finance· 7 days agoOver this period, the company intends to launch 20 new medicines, a number of which supposedly have...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
Motley Fool via Yahoo Finance· 7 days agoIf everything goes as planned, the company will produce at least eight new blockbuster medicines...
The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and...
Zacks via Yahoo Finance· 6 days agoSolid corporate earnings and rate cut bets have been driving stocks higher. In particular, NVIDIA's ...
Nvidia Insiders Have Sold $64 Million of NVDA Stock Since May 22
InvestorPlace· 12 hours agoFollowing a series of strong performances over the past several days, Nvidia (NASDAQ:NVDA) stock is...
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
Motley Fool via Yahoo Finance· 2 days agoTherapeutics. All three are in late-stage clinical trials with experimental therapies that could...
GameFi Sensation Mega Dice Zooms Past $1.3 Million In Blockbuster Presale
Inside Bitcoins· 2 days agoShaking up the crypto gaming landscape is the new GameFi token, Mega Dice ($DICE), which recently...
Layoffs, Reorganization May Hit Paramount Should Merger Fail | Entrepreneur
Entrpreneur· 9 hours agoA proposed merger between Paramount and Skydance, which was agreed to on Monday, per CNBC, is in...
Lionsgate’s MovieSphere Becomes First Major FAST Channel To Be Measured By Nielsen
Deadline Hollywood· 14 hours agoNielsen will report channel viewership in the same measurement used by traditional TV ad buyers....
‘Furiosa: A Mad Max Saga’ Dominates Global IMAX Box Office Circuit
Collider· 2 days agoFuriosa: A Mad Max Saga is dominating IMAX screens with the format making up 15% of the film's total...
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 6 days agoPfizer Once-booming COVID-19 vaccine sales have plunged, dragging down Pfizer's (NYSE: PFE) overall revenue and earnings. The big drugmaker faces a...